RaySearch Laboratories AB (publ) (LON:0GRZ)

Market Cap	665.39M
Revenue (ttm)	86.03M
Net Income (ttm)	14.69M
Shares Out	n/a
EPS (ttm)	0.43
PE Ratio	45.30
Forward PE	n/a
Dividend	0.15 (0.06%)
Ex-Dividend Date	May 23, 2025

Volume	9,965
Average Volume	16,847
Open	231.75
Previous Close	231.00
Day's Range	231.50 - 234.50
52-Week Range	6.15 - 15.70
Beta	1.15
RSI	51.02
Earnings Date	Apr 25, 2025

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment ...

• Industry: Prepackaged Software
• Founded: 1988
• Employees: 416
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0GRZ

Financial Performance

In 2024, RaySearch Laboratories AB's revenue was 1.19 billion, an increase of 16.62% compared to the previous year's 1.02 billion. Earnings were 203.51 million, an increase of 149.49%.

Financial numbers in SEK